Literature DB >> 19090558

Positron emission tomography (PET) used to image subclinical inflammation associated with ulcerative colitis (UC) in remission.

David T Rubin1, Bonnie L Surma, Samuel J Gavzy, Kerry M Schnell, Alana P Bunnag, Dezheng Huo, Daniel E Appelbaum.   

Abstract

BACKGROUND: Positron emission tomography (PET) using 18-fluorodeoxyglucose (18-FDG) is a noninvasive, functional imaging modality most often used to assess cancer. The aim of this study was to perform PET/computed tomography (CT) on patients with quiescent ulcerative colitis (UC) to understand the limits of this technology for assessing inflammatory activity.
METHODS: We identified patients diagnosed with UC in a strictly defined remission state. PET/CT was performed in standard fashion, using approximately 10 mCi of 18-FDG with a 60-minute uptake delay. Uptake in each of 4 colonic segments (recto-sigmoid [r-s], descending, transverse, and ascending), and distal small bowel were scored on a 3-point scale (0 = no uptake or uptake <or=liver; 1 = uptake somewhat >liver; 2 = uptake much greater than liver).
RESULTS: Ten patients participated in this study, 6 male. Eight had pancolitis, 1 had extensive colitis, and 1 had procto-sigmoiditis, with a median disease duration was 32 years. A PET scan was performed mean 37 days after endoscopy. Six patients had no increased 18-FDG uptake, 3 had increased uptake in the r-s region, 1 patient with r-s uptake also had ascending colon uptake, and 1 had ileal uptake with no colonic signal.
CONCLUSIONS: In this study, PET demonstrated inflammatory activity in the colon despite negative endoscopic, histologic, and symptom assessment. This has important implications in the understanding of UC disease quiescence. Further exploration of this highly sensitive modality should be performed.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19090558     DOI: 10.1002/ibd.20819

Source DB:  PubMed          Journal:  Inflamm Bowel Dis        ISSN: 1078-0998            Impact factor:   5.325


  8 in total

Review 1.  Role of scintigraphy in inflammatory bowel disease.

Authors:  Maria I Stathaki; Sophia I Koukouraki; Nikolaos S Karkavitsas; Ioannis E Koutroubakis
Journal:  World J Gastroenterol       Date:  2009-06-14       Impact factor: 5.742

2.  FDG PET/CT in Crohn's disease: correlation of quantitative FDG PET/CT parameters with clinical and endoscopic surrogate markers of disease activity.

Authors:  Babak Saboury; Ali Salavati; Alex Brothers; Sandip Basu; Thomas C Kwee; Marnix G E H Lam; Roland Hustinx; Edouard Louis; Drew A Torigian; Abass Alavi
Journal:  Eur J Nucl Med Mol Imaging       Date:  2013-11-20       Impact factor: 9.236

3.  Role of Positron Emission Tomography in Assessing Disease Activity in Ulcerative Colitis: Comparison with Biomarkers.

Authors:  Neha Berry; Saroj Kant Sinha; Anish Bhattacharya; K K Prasad; Chetana Vaishnavi; Kim Vaiphei; Jayanta Samanta; Raghavendra Prasada; Narendra Dhaka; Rakesh Kochhar
Journal:  Dig Dis Sci       Date:  2018-03-21       Impact factor: 3.199

Review 4.  Molecular imaging agents: impact on diagnosis and therapeutics in oncology.

Authors:  Marc E Seaman; Gianmarco Contino; Nabeel Bardeesy; Kimberly A Kelly
Journal:  Expert Rev Mol Med       Date:  2010-07-15       Impact factor: 5.600

5.  18F-Fluorodeoxyglucose positron-emission tomography (PET) can be used to assess inflammation non-invasively in Crohn's disease.

Authors:  Martin H Holtmann; Manuela Uenzen; Andreas Helisch; Anja Dahmen; Jonas Mudter; Martin Goetz; Mathias Schreckenberger; Peter R Galle; Peter Bartenstein; Markus F Neurath
Journal:  Dig Dis Sci       Date:  2012-05-09       Impact factor: 3.199

Review 6.  Radiographical evaluation of ulcerative colitis.

Authors:  Parakkal Deepak; David H Bruining
Journal:  Gastroenterol Rep (Oxf)       Date:  2014-05-19

7.  Role of molecular imaging in the management of patients affected by inflammatory bowel disease: State-of-the-art.

Authors:  Federico Caobelli; Laura Evangelista; Natale Quartuccio; Demetrio Familiari; Corinna Altini; Angelo Castello; Mariapaola Cucinotta; Rossella Di Dato; Cristina Ferrari; Aurora Kokomani; Iashar Laghai; Riccardo Laudicella; Silvia Migliari; Federica Orsini; Salvatore Antonio Pignata; Cristina Popescu; Erinda Puta; Martina Ricci; Silvia Seghezzi; Alessandro Sindoni; Martina Sollini; Letterio Sturiale; Anna Svyridenka; Vittoria Vergura; Pierpaolo Alongi
Journal:  World J Radiol       Date:  2016-10-28

8.  Evaluating [11C]PBR28 PET for Monitoring Gut and Brain Inflammation in a Rat Model of Chemically Induced Colitis.

Authors:  E Kurtys; J Doorduin; U L M Eisel; R A J O Dierckx; E F J de Vries
Journal:  Mol Imaging Biol       Date:  2017-02       Impact factor: 3.488

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.